Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 18

1.

Tau is required for progressive synaptic and memory deficits in a transgenic mouse model of α-synucleinopathy.

Singh B, Covelo A, Martell-Martínez H, Nanclares C, Sherman MA, Okematti E, Meints J, Teravskis PJ, Gallardo C, Savonenko AV, Benneyworth MA, Lesné SE, Liao D, Araque A, Lee MK.

Acta Neuropathol. 2019 Oct;138(4):551-574. doi: 10.1007/s00401-019-02032-w. Epub 2019 Jun 6.

PMID:
31168644
2.

Synaptic Depotentiation and mGluR5 Activity in the Nucleus Accumbens Drive Cocaine-Primed Reinstatement of Place Preference.

Benneyworth MA, Hearing MC, Asp AJ, Madayag A, Ingebretson AE, Schmidt CE, Silvis KA, Larson EB, Ebner SR, Thomas MJ.

J Neurosci. 2019 Jun 12;39(24):4785-4796. doi: 10.1523/JNEUROSCI.3020-17.2019. Epub 2019 Apr 4.

PMID:
30948476
3.

VU0810464, a non-urea G protein-gated inwardly rectifying K+ (Kir 3/GIRK) channel activator, exhibits enhanced selectivity for neuronal Kir 3 channels and reduces stress-induced hyperthermia in mice.

Vo BN, Abney KK, Anderson A, Marron Fernandez de Velasco E, Benneyworth MA, Daniels JS, Morrison RD, Hopkins CR, Weaver CD, Wickman K.

Br J Pharmacol. 2019 Jul;176(13):2238-2249. doi: 10.1111/bph.14671. Epub 2019 May 30.

PMID:
30924523
4.

A53T Mutant Alpha-Synuclein Induces Tau-Dependent Postsynaptic Impairment Independently of Neurodegenerative Changes.

Teravskis PJ, Covelo A, Miller EC, Singh B, Martell-Martínez HA, Benneyworth MA, Gallardo C, Oxnard BR, Araque A, Lee MK, Liao D.

J Neurosci. 2018 Nov 7;38(45):9754-9767. doi: 10.1523/JNEUROSCI.0344-18.2018. Epub 2018 Sep 24.

5.

Synapse-specific astrocyte gating of amygdala-related behavior.

Martin-Fernandez M, Jamison S, Robin LM, Zhao Z, Martin ED, Aguilar J, Benneyworth MA, Marsicano G, Araque A.

Nat Neurosci. 2017 Nov;20(11):1540-1548. doi: 10.1038/nn.4649. Epub 2017 Sep 25.

6.

G Protein-Gated K+ Channel Ablation in Forebrain Pyramidal Neurons Selectively Impairs Fear Learning.

Victoria NC, Marron Fernandez de Velasco E, Ostrovskaya O, Metzger S, Xia Z, Kotecki L, Benneyworth MA, Zink AN, Martemyanov KA, Wickman K.

Biol Psychiatry. 2016 Nov 15;80(10):796-806. doi: 10.1016/j.biopsych.2015.10.004. Epub 2015 Nov 10.

7.

Mechanisms underlying the activation of G-protein-gated inwardly rectifying K+ (GIRK) channels by the novel anxiolytic drug, ML297.

Wydeven N, Marron Fernandez de Velasco E, Du Y, Benneyworth MA, Hearing MC, Fischer RA, Thomas MJ, Weaver CD, Wickman K.

Proc Natl Acad Sci U S A. 2014 Jul 22;111(29):10755-60. doi: 10.1073/pnas.1405190111. Epub 2014 Jul 7.

8.

Putative kappa opioid heteromers as targets for developing analgesics free of adverse effects.

Le Naour M, Lunzer MM, Powers MD, Kalyuzhny AE, Benneyworth MA, Thomas MJ, Portoghese PS.

J Med Chem. 2014 Aug 14;57(15):6383-92. doi: 10.1021/jm500159d. Epub 2014 Jul 18.

9.

D-serine and serine racemase are localized to neurons in the adult mouse and human forebrain.

Balu DT, Takagi S, Puhl MD, Benneyworth MA, Coyle JT.

Cell Mol Neurobiol. 2014 Apr;34(3):419-35. doi: 10.1007/s10571-014-0027-z. Epub 2014 Jan 17.

10.

Multiple risk pathways for schizophrenia converge in serine racemase knockout mice, a mouse model of NMDA receptor hypofunction.

Balu DT, Li Y, Puhl MD, Benneyworth MA, Basu AC, Takagi S, Bolshakov VY, Coyle JT.

Proc Natl Acad Sci U S A. 2013 Jun 25;110(26):E2400-9. doi: 10.1073/pnas.1304308110. Epub 2013 May 31.

11.

Altered acquisition and extinction of amphetamine-paired context conditioning in genetic mouse models of altered NMDA receptor function.

Benneyworth MA, Coyle JT.

Neuropsychopharmacology. 2012 Oct;37(11):2496-504. doi: 10.1038/npp.2012.108. Epub 2012 Jul 4.

12.

Cell selective conditional null mutations of serine racemase demonstrate a predominate localization in cortical glutamatergic neurons.

Benneyworth MA, Li Y, Basu AC, Bolshakov VY, Coyle JT.

Cell Mol Neurobiol. 2012 May;32(4):613-24. doi: 10.1007/s10571-012-9808-4. Epub 2012 Feb 24.

13.

Failure of NMDA receptor hypofunction to induce a pathological reduction in PV-positive GABAergic cell markers.

Benneyworth MA, Roseman AS, Basu AC, Coyle JT.

Neurosci Lett. 2011 Jan 25;488(3):267-71. doi: 10.1016/j.neulet.2010.11.043. Epub 2010 Nov 19.

14.

Discordant behavioral effects of psychotomimetic drugs in mice with altered NMDA receptor function.

Benneyworth MA, Basu AC, Coyle JT.

Psychopharmacology (Berl). 2011 Jan;213(1):143-53. doi: 10.1007/s00213-010-2023-4. Epub 2010 Sep 24.

15.

Targeted disruption of serine racemase affects glutamatergic neurotransmission and behavior.

Basu AC, Tsai GE, Ma CL, Ehmsen JT, Mustafa AK, Han L, Jiang ZI, Benneyworth MA, Froimowitz MP, Lange N, Snyder SH, Bergeron R, Coyle JT.

Mol Psychiatry. 2009 Jul;14(7):719-27. doi: 10.1038/mp.2008.130. Epub 2008 Dec 9. Erratum in: Mol Psychiatry. 2010 Nov;15(11):1122.

16.

Chronic phenethylamine hallucinogen treatment alters behavioral sensitivity to a metabotropic glutamate 2/3 receptor agonist.

Benneyworth MA, Smith RL, Sanders-Bush E.

Neuropsychopharmacology. 2008 Aug;33(9):2206-16. Epub 2007 Oct 24.

17.

A selective positive allosteric modulator of metabotropic glutamate receptor subtype 2 blocks a hallucinogenic drug model of psychosis.

Benneyworth MA, Xiang Z, Smith RL, Garcia EE, Conn PJ, Sanders-Bush E.

Mol Pharmacol. 2007 Aug;72(2):477-84. Epub 2007 May 25.

PMID:
17526600
18.

Complex discriminative stimulus properties of (+)lysergic acid diethylamide (LSD) in C57Bl/6J mice.

Benneyworth MA, Smith RL, Barrett RJ, Sanders-Bush E.

Psychopharmacology (Berl). 2005 Jun;179(4):854-62. Epub 2005 Jan 12.

PMID:
15645221

Supplemental Content

Loading ...
Support Center